SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001477932-18-003888
Filing Date
2018-08-09
Accepted
2018-08-09 11:02:02
Documents
39
Period of Report
2018-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q oncx_10q.htm 10-Q 268549
2 CERTIFICATION oncx_ex311.htm EX-31.1 7605
3 CERTIFICATION oncx_ex321.htm EX-32.1 2786
  Complete submission text file 0001477932-18-003888.txt   1972542

Data Files

Seq Description Document Type Size
4 XBRL INSTANCE DOCUMENT oncx-20180630.xml EX-101.INS 286192
5 XBRL TAXONOMY EXTENSION SCHEMA oncx-20180630.xsd EX-101.SCH 36206
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE oncx-20180630_cal.xml EX-101.CAL 23997
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE oncx-20180630_def.xml EX-101.DEF 125604
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE oncx-20180630_lab.xml EX-101.LAB 161285
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE oncx-20180630_pre.xml EX-101.PRE 152297
Mailing Address 14405 WALTERS ROAD SUITE 780 HOUSTON TX 77014
Business Address 14405 WALTERS ROAD SUITE 780 HOUSTON TX 77014 281-402-3167
Oncolix, Inc. (Filer) CIK: 0001584137 (see all company filings)

IRS No.: 463046340 | State of Incorp.: FL | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-55545 | Film No.: 181003973
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences